Molecular profiling and targeted therapy in advanced endometrial cancer.

被引：0
|
作者：
Wilson, Michelle K.
Bedard, Philippe L.
Joshua, Anthony M.
Mackay, Helen
Butler, Marcus O.
Dhani, Neesha C.
Lheureux, Stephanie
Martin-Lorente, Cristina
Rodriguez-Freixinos, Victor
Clarke, Blaise
Shaw, Patricia
Milea, Anca
Wang, Lisa
Kamel-Reid, Suzanne
Stockley, Tracy
Bruce, Jeff
Pugh, Trevor John
Oza, Amit M.
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Pathol & Lab Med, Toronto, ON, Canada
[5] Univ Hlth Network, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[7] Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON M4X 1K9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.5589
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5589
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The association of tumor molecular profiling and clinical trial enrollment in an advanced/recurrent endometrial cancer cohort
    Mehta, Naaman
    Lee, Sarah
    Kenkel, Camryn
    Nawlo, Jude
    Jimenez, Edward
    Pothuri, Bhavana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A143 - A144
  • [42] Molecular profiling of advanced breast cancer patients and benefit obtained from matched targeted therapy in early phase clinical trials
    De Mattos-Arruda, L.
    Oliveira, M.
    Navarro, A.
    Vilaro, M.
    Nuciforo, P.
    Vivancos, A.
    Seoane, J.
    Rodon, J.
    Cortes, J.
    Saura, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S418 - S418
  • [43] The molecular landscape of pembrolizumab and lenvatinib treatment in endometrial cancer.
    Carballo, Erica V.
    Wu, Sharon
    Penn, Courtney A.
    Angara, Kartik
    Thaker, Premal H.
    Oberley, Matthew James
    Herzog, Thomas J.
    Starbuck, Kristen D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Hormone replacement therapy for survivors of breast and endometrial cancer.
    DiSaia P.J.
    Brewster W.R.
    Current Oncology Reports, 2002, 4 (2) : 152 - 158
  • [45] Targeted Therapy for advanced Gastric Cancer
    Pommer, Peter
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (22) : 1604 - 1604
  • [46] Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer.
    Shen, Sherry
    Ma, Weining
    Zhou, Qin
    Iasonos, Alexia
    Zhang, Yanming
    Ross, Dara S.
    Makker, Vicky
    Chui, Michael Herman
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine
    Tsimberidou, Apostolia-Maria
    CURRENT PROBLEMS IN CANCER, 2017, 41 (03) : 176 - 181
  • [48] Molecular-targeted first-line therapy for advanced gastric cancer
    Song, Huan
    Zhu, Jianwei
    Lu, DongHao
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (07):
  • [49] Endometrial cancer: redefining the molecular-targeted approach
    da Silva, Jesse Lopes
    Paulino, Eduardo
    Dias, Mariane Fontes
    de Melo, Andreia Cristina
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 1 - 11
  • [50] Endometrial cancer: redefining the molecular-targeted approach
    Jesse Lopes da Silva
    Eduardo Paulino
    Mariane Fontes Dias
    Andréia Cristina de Melo
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1 - 11
12345